- Active Pharmaceutical Ingredients
- 酒石酸伐尼克兰
- Aprepitant, Fosapitant Intermediates
- 福沙匹坦双葡甲胺
- 维格列汀
- 艾氟康唑
- Luliconazole Intermediate
- 钆特酸葡胺
- Succinyl Alcohol Intermediate
- Mirabillon Intermediate
- Atazanavir Intermediate
- Intermediate
- 酒石酸伐尼克兰
- 阿瑞匹坦 287930-73-8
- 阿瑞匹坦 127852-28-2
- 阿瑞匹坦 287930-75-0
- 阿瑞匹坦 200000-59-5
- 阿瑞匹坦 155742-64-6
- 阿瑞匹坦 252742-72-6
- 福沙匹坦双葡甲胺 990-91-0
- 福沙匹坦双葡甲胺 265121-01-5
- 维格列汀 207557-35-5
- 维格列汀 702-82-9
- 艾氟康唑 144230-50-2
- 艾氟康唑 133775-25-4
- 艾氟康唑 127000-90-2
- 钆特酸葡胺
- 米拉贝隆
- 卢立康唑 98873-55-3
- 卢立康唑 126534-31-4
- 硫酸阿扎那韦
- 硼替佐米 179324-87-9
- 硼替佐米 114457-94-2
- 硼替佐米 205393-22-2
- 布林佐胺
- 利伐沙 446292-08-6
- 利伐沙 446292-07-5
- 西那卡塞 1005450-55-4
- 西那卡塞 585-50-2
- Eletriptan Intermediate
- 茚达特罗 312753-53-0
- 茚达特罗 173140-90-4
- Sitagliptin Intermediate
- Fosanavir Calcium Intermediate
Popular information
Diabetes medication Vildagliptin 274901-16-5
【Catalog number】AP2401
【CAS #】654671-77-9
【Molecular formula】C16H20F6N5O6P
【Product Brief】CAS 274901-16-5 Vidagliptin, the English name is Vildagliptin, the American Chemical Abstracts registration number is cas 274901-16-5.
Alias (-)-(2S) -1-[[(3-hydroxytricyclo [3.3.1.1 [3,7]] silane-1-yl) amino] acetyl] pyrrolidine-2-carbonitrile; Vita Liptin; (-)-(2S) -1-[[(3-hydroxytricyclo [3.3.1.1 [3,7]] decane-1-yl) amino] acetyl] pyrrolidine-2-carbonitrile Vedagliptin Vedagliptin Vedagliptin
Catalog number AP2700
CAS # 274901-16-5
Molecular formula C17H25N3O2
Molecular weight 303.40
Structural formula
Product introduction
CAS 274901-16-5 Vidagliptin, the English name is Vildagliptin, the American Chemical Abstracts registration number is cas 274901-16-5.
Vinalitin (cas 274901-16-5) is a selective, competitive, and reversible DPP_4 inhibitor. By combining with DPP-4 to form a DPP-4 complex to inhibit the activity of the enzyme, while increasing the concentration of GLP-1 and promoting the production of insulin by islet B cells, it also lowers the concentration of glucagon, thereby reducing blood glucose, and has no effect on body weight. Significant impact. This product is an oral anti-diabetic drug.
VIWIT 沪ICP备12014533号-1
